UroGen Pharma (NASDAQ:URGN) stock in focus as company acquires oncolytic virus ICVB-1042 from IconOVir Bio, to design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback